Graf Akcie ACRX (Acelrx Pharmaceuticals Inc). Diskuze k akciím ACRX. Aktuální informace ACRX.

Základní informace o společnosti Acelrx Pharmaceuticals Inc (Akcie ACRX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 121.49M
Hodnota podniku (EV) N/A
Tržby 3.06M
EBITDA N/A
Zisk -36.66
Růst v tržbách Q/Q -84.85 %
Růst v tržbách Y/Y -30.34 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 0.14
EV/Sales 31.81
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 39.70
P/FCF N/A
Price/Book -2.18
Účetní hodnota na akcii -0.46
Hotovost na akcii 0.36
FCF vůči ceně -29.47 %
Počet zaměstnanců 54
Tržba na zaměstnance 56.667k
Profit margin -745.55 %
Operating margin -1,223.46 %
Gross margin -11.37 %
EBIT margin -1,103.59 %
EBITDA margin -1,019.54 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 0.00 %
EPS - Očekávaný růst příští rok -30.00 %
Return on assets -48.97 %
Return on equity 82.88 %
ROIC -47.03 %
ROCE -52.44 %
Dluhy/Equity -2.19
Čistý dluh/EBITDA 1.67
Current ratio 3.88
Quick Ratio 3.79
Volatilita 4.55
Beta 1.03
RSI 44.02
Cílová cena analytiků 5
Známka akcie (dle analytiků) N/A
Insider ownership 1.94 %
Institutional ownership 34.86 %
Počet akcií 119.18M
Procento shortovaných akcií 4.19 %
Short ratio 7.29 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2011
Země United States

Finanční výsledky akcie ACRX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2.289$2.151$7.995$17.357$19.263$5.217
Cost Of Goods Sold$6.806$3.976$10.659$12.315$1.77-
Gross Profit$-4.517$-1.825$-2.664$5.042$17.493$5.217
Research And Development Expenses$4.661$13.137$19.409$21.402$22.488$24.52
SG&A Expenses$45.027$20.765$16.609$15.597$14.203$18.346
Other Operating Income Or Expenses------
Operating Expenses$56.494$37.878$46.677$49.314$39.217$42.866
Operating Income$-54.205$-35.727$-38.682$-31.957$-19.954$-37.649
Total Non-Operating Income/Expense$0.968$-11.42$-13.527$-11.234$-3.685$4.296
Pre-Tax Income$-53.237$-47.147$-52.209$-43.191$-23.639$-33.353
Income Taxes$0.003$0.002$-0.701$-0.034$0.76-
Income After Taxes$-53.24$-47.149$-51.508$-43.157$-24.399$-33.353
Other Income------
Income From Continuous Operations$-53.24$-47.149$-51.508$-43.157$-24.399$-33.353
Income From Discontinued Operations------
Net Income$-53.24$-47.149$-51.508$-43.157$-24.399$-33.353
EBITDA$-52.537$-35.152$-36.938$-29.905$-17.97$-36.567
EBIT$-54.205$-35.727$-38.682$-31.957$-19.954$-37.649
Basic Shares Outstanding795847454443
Shares Outstanding795847454444
Basic EPS$-0.67$-0.81$-1.10$-0.95$-0.55$-0.77
EPS - Earnings Per Share$-0.67$-0.81$-1.10$-0.95$-0.60$-0.91
# 2020 2019 2018 2017 2016 2015
Current Ratio5.26696.78014.64228.73849.30735.5566
Long-term Debt / Capital-0.98160.4428-0.45221.40130.3310.2786
Debt/Equity Ratio-0.60722.8194-0.523-4.03770.63180.5331
Gross Margin-197.3351-84.8443-33.320829.048890.8114100
Operating Margin-2368.064-1660.948-483.8275-184.1159-103.5872-721.66
EBIT Margin-2368.064-1660.948-483.8275-184.1159-103.5872-721.66
EBITDA Margin-2295.194-1634.217-462.0138-172.2936-93.2877-700.9201
Pre-Tax Profit Margin-2325.775-2191.864-653.0206-248.8391-122.7171-639.3138
Net Profit Margin-2325.906-2191.957-644.2527-248.6432-126.6625-639.3138
Asset Turnover0.02510.01780.10580.17360.15070.0604
Inventory Turnover Ratio2.06564.655711.14965.71733.7983-
Receiveable Turnover4.40195.36415.21532.97575.8621-
Days Sales In Receivables82.918368.045169.9869122.66262.2639-
ROE - Return On Equity128.5432-1108.608141.083808.6384-73.6841-71.4871
Return On Tangible Equity128.5431-1108.606141.083808.637-73.684-71.4871
ROA - Return On Assets-58.2775-39.1171-68.1756-43.16-19.0938-38.5959
ROI - Return On Investment254.7246-617.6995204.8846-324.4888-49.2969-51.5734
Book Value Per Share-0.52050.054-0.7173-0.11770.73141.0674
Operating Cash Flow Per Share-0.14850.13710.0138-0.20.3287-0.7651
Free Cash Flow Per Share-0.17840.17440.0446-0.24940.4202-0.8066

Porovnání s konkurencí: Akcie ACRX

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ACRX 0.00 N/A -30.34 % -30.00 % 82.88 % -2.18 -745.55 %
Akcie BDSI 12.15 0.76 19.93 % -33.33 % 31.75 % 3.70 16.43 %
Akcie CARA 51.31 N/A N/A % 11.43 % 4.12 % 2.68 6.23 %
Akcie DRRX N/A N/A -88.00 % 0.00 % -42.18 % 6.81 -1.93 %
Akcie REPH 0.00 N/A -20.17 % 0.00 % 669.75 % -4.05 -41.36 %

Nedávné obchody insiderů: Akcie ACRX

Jméno Obchod Cena Objem
Lawrence G Hamel
Chief Development Officer
Nákup
28 Feb 2019
$2.81 $10,346
Vincent J. Angotti
Chief Executive Officer
Nákup
28 Feb 2019
$2.81 $9,088
Badri N Dasu
Chief Engineering Officer
Nákup
28 Feb 2019
$2.81 $25,869
Raffi Asadorian
Chief Financial Officer
Nákup
28 Feb 2019
$2.81 $10,248
Mark G Edwards
Director
Nákup
12 Mar 2019
$2.99 $56,810
Vincent J. Angotti
Chief Executive Officer
Nákup
5 Jun 2019
$2.31 $11,550
Mark G Edwards
Director
Nákup
23 Aug 2019
$2.19 $32,850
Vincent J. Angotti
Chief Executive Officer
Nákup
11 Nov 2019
$1.79 $14,998
Mark G Edwards
Director
Nákup
12 Nov 2019
$1.78 $44,500
Vincent J. Angotti
Chief Executive Officer
Nákup
15 Jun 2020
$1.33 $10,038
Adrian Adams
Director
Nákup
15 Jun 2020
$1.29 $129,000

Diskuze k akciím ACRX